Electrophoresis Market

Electrophoresis Market Outlook for (2023 to 2033)

The global electrophoresis market is expected to value USD 3,523.50 million by 2033. The electrophoresis market is projected to rise at a CAGR of 4.5% through 2033, with a present valuation of USD 2,268.8 million in 2023.

Attributes	Details
Electrophoresis Market Size, 2022	USD 2,185.8 million
Electrophoresis Market Size, 2023	USD 2,268.8 million
Electrophoresis Market Size, 2033	USD 3,523.50 million
Value-based CAGR (2023 to 2033)	4.5%

Analyzing the Impact of Emerging Trends on the Adoption of Electrophoresis

• Increasing demand for personalized medications and tailored targeted therapies due to the growing incidence of chronic diseases is creating a positive outlook for the electrophoresis market. Since the process of drug discovery requires electrophoresis while qualifying for different tests, increasing drug developments are predicted to drive sales of electrophoresis.
• Companies from developed regions like North America and Europe typically outsource clinical trials and drug research activities to emerging countries like India and China. As a result, these economies are investing in research capacities and healthcare infrastructure. Along with these factors, the high availability of qualified and skilled labor in these countries is creating a lucrative opportunity for obtaining biotech projects.
• Governments of emerging economies are taking significant measures to boost the overall growth of the domestic biotech industry by providing tax exemptions for research and development and improving the overall budget and funding, thus inviting foreign direct investments.

Historical Growth of the Electrophoresis Market Vs. Forecast Outlook

Attributes	Details
Electrophoresis Market Size (2022)	USD 2,185.8 million
Value-based CAGR (2018 to 2023)	3.4%

The electrophoresis market valuation was USD 2,185.8 million in 2022. It is expected to reach USD 3,523.5 million by 2033. The following factors have led to market growth during the historical period:

• Wide-ranging applications of gel electrophoresis in genomic research, including genetic mapping, chromosomal assignments of genes, and production of artificial chromosome libraries.
• Increasing DNA and protein mapping practices and drug development are creating demand for electrophoresis.
• Surging academic research is boosting the advancement of electrophoresis utilization.
• The rising incidence rate of chronic disorders like infectious diseases, genetic disorders, and cancer is supplementing the demand for electrophoresis equipment in disease diagnosis. In clinical laboratory setups, electrophoresis is used to gauge lipoproteins to detect cardiovascular or other chronic illnesses. Apart from this, the growth of chronic respiratory disease treatment is also expanding electrophoresis applications.

Sales of electrophoresis equipment are predicted to increase at a steady CAGR of 4.5% through 2033. Mentioned below are the key factors helping the market to advance:

• Seismic shift toward the proteomics market is pushing technological advancements forward, assisting drug delivery researchers by offering higher throughput, improved resolution, and added sensitivity.
• Increasing technological developments in electrophoresis, like automated systems, swift results, and surging government investments, are expected to fuel market expansion.
• Increasing volumes of genetic testing are predicted to drop the average selling prices of tools and services. The surging use of genomic testing and research, along with the reduced cost of instruments, is predicted to generate opportunities for the expansion of electrophoresis businesses, especially in developing countries.

Country-wise Insights

Countries	Market CAGR (2023 to 2033)
Australia	3.8%
China	5.1%
India	5.9%
The United Kingdom	4.7%

India Competing for Greater Share in the Asia Pacific

Country	India
Market CAGR	5.9%

India is an important market for electrophoresis in the Asia Pacific. Over the assessment period, the country is predicted to expand at a CAGR of 5.9%, slightly higher than other countries in the region. Backing the market’s growth in India are the following factors:

• Rising use of automated technologies into a unified platform for drug discovery and platform.
• Enhancing medical setup in the country.
• Large population enduring chronic disorders.

New Innovations in China Pushing the Electrophoresis Market Forward

China is faring well in the electrophoresis market. Given below are the factors that are supporting the CAGR of 5.1% through 2033.

Factors such as increasing research and development activities in biotechnology and life sciences contribute to the growth of electrophoresis market in China. The biopharmaceutical industry in China is growing steadily as electrophoresis plays an important role in research development for biopharmaceutical products.

Budding Market for Electrophoresis in Australia Attracting Investments

Country	Australia
Market CAGR	3.8%

The electrophoresis market in Australia is predicted to register a CAGR of 3.8% over the forecast period. Following factors lead the market growth

• Surging investments in life sciences research are augmenting the sales of electrophoresis.
• High incidence of chronic diseases, like diabetes and cancer in Australia is raising the demand for electrophoresis to detect and monitor these disorders.
• Emerging field of personalized medicine that deploys genetic information to customize treatments as per the needs of individual patients. Electrophoresis finds application in the analysis of genetic data and identification of genetic mutations that lead to that disease.

The United Kingdom Accounts for 4.7% CAGR through 2033

The market is highly penetration with established players in the country, therefore new entrants are predicted to struggle for their share in the market. Given below are the key factors behind the market growth:

• Surging inclination for horizontal electrophoresis in the United Kingdom.
• Robust healthcare system that combines advanced technological procedures.
• Surging patient population suffering from chronic diseases.
• Increasing investments in healthcare sector to offer efficient medical facilities.

Category-wise Insights

Reagents and Consumables Lead the Market by Product

Top Product	Reagents and Consumables
Market Share in 2023	48.67%

Consumption of electrophoresis in the form of reagents and consumables is appreciating the segment’s value. According to the study, the segment holds a share of 48.67% in 2023. Extensive application of consumables and reagents in electrophoresis and related techniques like PCR is predicted to increase this segment's sales.

Pharma and Biotech Companies Gaining Continued Traction

Top End-use Industry	Pharma and Biotech Companies
Market Share	27%

The pharma and biotech companies are predicted to account for 27% market share in 2023. This end-use industry segment is predicted to expand with the emerging discoveries in therapeutic approaches to develop new drugs. The following factors are fueling the segment’s growth:

• Increasing demand to detect the quality and purity of biological products is boosting the application of electrophoresis in pharma and biotech companies. For instance, electrophoresis is used to diagnose vaccines for contamination and confirm therapeutic proteins' purity.
• The surging requirement for electrophoresis in the production of drugs is also contributing to the increasing utilization of electrophoresis in pharma and biotech companies.

Key Players Vying for a Larger Market Share in Electrophoresis Market

Key players in the electrophoresis market are funding collaborations with research institutes for the advancement of electrophoresis techniques. Surging research and development in this field has resulted in expanded applications of electrophoresis in quality control and food safety.

Players are acquiring smaller companies to broaden their offerings and scope in new markets. Market participants are partnering with other companies like system integrators and distributors to consolidate their sales channels and reach new customers, increasing their market share.

Key Developments Observed in the Electrophoresis Market

• In September 2021, SCIEX revealed its capillary electrophoresis solution called BioPhase 8800 system. The novel, advanced multi-capillary system can process eight samples at a time, thus warranting sample consistency and precise results.
• In September 2019, Bio-Rad Laboratories, Inc. unveiled the Science of Opioid Dependence Kit. The kit provides undergraduate and high school educators with a hands-on DNA electrophoresis activity to learn complex genetics due to the opioid crisis.
• In March 2023, researchers in Japan created a new method to purify DNA nanostructures that can be used to make molecular robot bodies functional. Researchers used gel electrophoresis to segregate aggregates and target DNA nanostructures.

Key Players

• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Helena Laboratories Corporation
• Hoefer, Inc. (Harvard Biosciences)
• Merck KGaA
• PerkinElmer Inc.
• SCIEX
• SERVA Electrophoresis GmbH
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Shimadzu Corporation
• Takara Bio, Inc.
• TBG Diagnostic Ltd
• Cleaver Scientific
• QIAGEN N.V.
• Eurogentec
• Sebia Group
• Analytik Jena
• Lonza Group

Report Scope as per Electrophoresis Market Analysis

Attribute	Details
Estimated Market Size (2023)	USD 2,268.8 million
Projected Market Valuation (2033)	USD 3,523.50 million
Value-based CAGR (2023 to 2033)	4.5%
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	USD million for Value
Key Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered	The United States, Canada, Brazil, Mexico, Argentina, Germany, the United Kingdom, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, North Africa, and South Africa
Key Market Segments Covered	Product, End User, and Region
Key Companies Profiled	Agilent Technologies; Bio-Rad Laboratories, Inc.; Helena Laboratories Corporation; Hoefer, Inc. (Harvard Biosciences); Merck KGaA; PerkinElmer Inc.; SCIEX; SERVA Electrophoresis GmbH; Thermo Fisher Scientific Inc.; Danaher Corporation; Shimadzu Corporation; Takara Bio, Inc.; TBG Diagnostic Ltd; Cleaver Scientific; QIAGEN N.V.; Eurogentec; Sebia Group; Analytik Jena; Lonza Group

Key Market Segments Covered in Electrophoresis Market Research

By Product:

• Instruments
  • Horizontal Systems
  • Vertical Systems
  • Capillary Electrophoresis Systems
  • Automatic Electrophoresis Systems
• Reagents and Consumables
  • Gel
    • Polyacrylamide Gel Electrophoresis
    • Agarose Gel Electrophoresis
    • Others
  • Buffers & Others
• Software

By End-use Industry:

• Hospitals
• Diagnostic Laboratories
• Pharma & Biotech Companies
• CROs and CMOs
• Academic & Research Institutes
• Forensic Laboratories

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Electrophoresis Market?

The electrophoresis market valuation is USD 2,268.8 million in 2023.

What is the Growth Potential of the Electrophoresis Market?

The market is expected to expand at a CAGR of 4.5% through 2033.

What is the Expected Value of the Electrophoresis Market?

The electrophoresis market is anticipated to account for USD 3,523.50 million by 2033.

Which Country is Predicted to Witness Significant Growth?

India is predicted to witness significant growth in the market.

Which Product is High in Demand in Electrophoresis Market?

Reagents and consumables are in high demand in the market.